This inventor holds 3 USPTO granted patents. Top assignees: Mitsubishi Petrochemical Company Limited, Unitika Ltd.. Active years: 1982-1984.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ibaraki, JP (1982)
- Ami, JP (1982)
- Ibaragi, JP (1984)
Company Filing History:

Years Active: 1982-1984
Title: Naoto Miwa: Innovator in Analytical Chemistry
Introduction
Naoto Miwa is a distinguished inventor based in Ibaraki, Japan. He has made significant contributions to the field of analytical chemistry, particularly in the development of methods for measuring enzyme activity. With a total of 3 patents to his name, Miwa's work has had a notable impact on medical diagnostics.
Latest Patents
Miwa's latest patents include innovative analytical compositions and methods. One of his notable inventions is a measuring composition that comprises glucokinase and glucose-6-phosphate dehydrogenase. This composition is designed to enhance the accuracy of glucose measurements. Another significant patent is a method for measuring creatine kinase activity. This method utilizes a composition that includes phosphoglycerate kinase and glyceraldehyde-3-phosphate dehydrogenase, which are essential for the reliable measurement of creatine kinase activity.
Career Highlights
Throughout his career, Naoto Miwa has worked with prominent companies such as Mitsubishi Petrochemical Company Limited and Unitika Ltd. His experience in these organizations has allowed him to refine his skills and contribute to various innovative projects in the field of analytical chemistry.
Collaborations
Miwa has collaborated with several notable professionals in his field, including Seiichi Kawarabuki and Toshiyuki Sai. These collaborations have further enriched his research and development efforts.
Conclusion
Naoto Miwa's contributions to analytical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to advance the field and improve diagnostic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile